|
Market Closed -
NYSE
04:00:03 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 1,283.66 USD | +3.49% |
|
+8.54% | +19.45% |
| 05:15pm | Dow outperforms as Wall Street rises, healthcare stocks lead gains | RE |
| 04:01pm | Dow leads Wall Street higher, investors focus on healthcare stocks | RE |
| Market Cap | 1,106B 984B 912B 826B 1,553B 104,735B 1,579B 10,944B 4,299B 54,810B 4,147B 4,061B 174,851B | P/E 2026 * |
35.7x | P/E 2027 * | 27.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1,132B 1,008B 934B 846B 1,591B 107,264B 1,617B 11,208B 4,403B 56,133B 4,247B 4,159B 179,072B | EV / Sales 2026 * |
12.8x | EV / Sales 2027 * | 10.9x |
| Free-Float |
99.84% | Yield 2026 * |
0.55% | Yield 2027 * | 0.62% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LLY | Delayed | |
CBOE
| LLY | Real-time | |
Tradegate
| LLY | Real-time | |
Xetra
| LLY | Delayed | |
Boerse Muenchen
| LLY | Real-time | |
CBOE
| Real-time | ||
Borsa Italiana
| 1LLY | End-of-day quote | |
Börse Stuttgart
| LLY | Delayed | |
Deutsche Boerse AG
| LLY | Delayed | |
Mexican S.E.
| LLY * | End-of-day quote | |
Lima
| LLYUS | End-of-day quote | |
Bulgaria S.E.
| LLY | End-of-day quote | |
Santiago S.E.
| LLYCL | End-of-day quote | |
Santiago S.E.
| LLY | End-of-day quote | |
Swiss Exchange
| LLY | Delayed | |
CBOE
| LEL | Real-time | |
Wiener Boerse
| LLYC | End-of-day quote | |
CBOE
| LEL | Real-time | |
Warsaw S.E.
| LILY | Delayed |
Last Transcript: Eli Lilly and Company
| 1 day | +4.04% | ||
| 1 week | +10.04% | ||
| Current month | +10.94% | ||
| 1 month | +10.20% | ||
| 3 months | +11.92% | ||
| 6 months | +39.54% | ||
| Current year | +19.45% |
| 1 week | 1,174.24 | 1,311.75 | |
| 1 month | 1,131.21 | 1,311.75 | |
| Current year | 850.51 | 1,311.75 | |
| 1 year | 793.82 | 1,311.75 | |
| 3 years | 547.61 | 1,311.75 | |
| 5 years | 231.87 | 1,311.75 | |
| 10 years | 64.18 | 1,311.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 2016-12-31 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 2024-09-08 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 66 | 2004-12-31 |
Ralph Alvarez
BRD | Director/Board Member | 70 | 2009-03-31 |
| Director/Board Member | 54 | 2011-12-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/21/26 | Free | Director | 11 | 0.0000% | ||
| 9/21/26 | Free | Director | 14 | 0.0000% | ||
| 9/21/26 | Free | Director | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.49% | +10.04% | +58.68% | +119.56% | 1,106B | ||
| +2.19% | +4.32% | +33.88% | +69.52% | 612B | ||
| +2.26% | +5.37% | +24.57% | +97.69% | 500B | ||
| +2.58% | +8.31% | +37.43% | +63.51% | 367B | ||
| +3.25% | +4.45% | +71.80% | +44.44% | 354B | ||
| +1.85% | +5.45% | +21.38% | +49.26% | 286B | ||
| +1.76% | +4.92% | +0.48% | +20.31% | 256B | ||
| +3.29% | +6.32% | +44.71% | +57.43% | 230B | ||
| +2.25% | +5.81% | +27.13% | +101.17% | 190B | ||
| +1.83% | +1.87% | -23.77% | -61.82% | 170B | ||
| Average | +2.58% | +1.92% | +29.63% | +56.11% | 407.05B | |
| Weighted average by Cap. | +2.89% | +2.21% | +38.00% | +74.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 88.58B 78.85B 73.07B 66.22B 124B 8,392B 127B 877B 344B 4,391B 332B 325B 14,009B | 102B 90.85B 84.2B 76.3B 143B 9,669B 146B 1,010B 397B 5,060B 383B 375B 16,142B |
| Net income | 30.89B 27.49B 25.48B 23.09B 43.39B 2,926B 44.12B 306B 120B 1,531B 116B 113B 4,885B | 40.44B 35.99B 33.36B 30.23B 56.81B 3,831B 57.76B 400B 157B 2,005B 152B 149B 6,395B |
| Net Debt | 26.69B 23.76B 22.02B 19.95B 37.5B 2,529B 38.13B 264B 104B 1,323B 100B 98.05B 4,221B | 3.27B 2.91B 2.69B 2.44B 4.59B 309B 4.66B 32.32B 12.7B 162B 12.25B 12B 516B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $1,283.66 | +3.49% | 2,959,648 |
| 26-10-19 | $1,240.34 | -1.33% | 1,960,268 |
| 26-10-16 | $1,257.03 | +0.43% | 2,413,950 |
| 26-10-15 | $1,251.61 | +3.55% | 3,755,241 |
| 26-10-14 | $1,208.74 | +3.62% | 3,167,443 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions


















